Join
Live feed
·
PRReleasevia Quantisnow
AstraZeneca PLC logo

Baxdrostat met the primary endpoint in Bax24 Phase III trial in patients with resistant hypertension

ByQuantisnow·Wall Street's wire, on your screen.
AZN· AstraZeneca PLC
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AZN (AstraZeneca PLC) and more on Quantisnow.